Impact of microplastics on the intestinal microbiota: A systematic review of preclinical evidence

Aims: We systematically review the in vivo preclinical evidence on the impact of microplastics (MPs) on the intestinal microbiota and morphofunctional changes involving the intestinal mucosa. Methods: By using a comprehensive and structured search in electronic databases 28 original studies were recovered and analyzed. Key findings: Zebrafish and mice were the main animal models, while the dose and shape of MPs used were quite heterogeneous. Studies show that MPs are potential triggers of intestinal dysbiosis, which has been characterized by enrichment of Firmicutes, Proteobacteria and Chlamydia. Conversely, there was a reduction in Bacteroidetes phylum abundance. By trapping and stimulating intestinal inflammatory infiltrate, exposure to MPs increased intestinal permeability and the expression of immune signatures associated with inflammation, such as IL-1 alpha, IL 1(i, TNF-alpha, IFN-gamma and IL-6. Significance: Thus, current evidence supports potential inflammatory and dysbiotic properties of MPs. In addition, the data indicate that MPs can display structural changes secondary to exposure to MPs. Analysis of methodological quality indicated that current preclinical evidence is at high risk of bias. We hope that controlling that bias sources described in this systematic review will be useful to improve the quality of reports.

Automated summary

This review systematically examines the effects of microplastics on the intestinal microbiota and morphofunctional changes of the intestinal mucosa in vivo. The findings suggest that microplastics may contribute to intestinal dysbiosis and structural changes in the intestinal mucosa.